Dynamic changes in macrophage polarization during the resolution phase of periodontal disease

Juhi R. Uttamani,Varun Kulkarni,Araceli Valverde,Raza Ali Naqvi,Thomas Van Dyke,Salvador Nares,Afsar R. Naqvi
DOI: https://doi.org/10.1002/iid3.70044
2024-10-24
Immunity Inflammation and Disease
Abstract:This is the first translational studies to longitudinally assess the M/M2 MΦ profiles before and after therapy in periodontitis subjects and can serve as the first step in examining current treatment strategies to include investigations on the role of macrophage immune mediated regulatory networks governing periodontal disease pathogenesis. Our findings highlight the immuno‐modulatory role of M1/M2 MΦ polarization in the periodontal disease pathogenesis and likewise, the impact of periodontal therapy in causing a switch toward M2 MΦ phenotype. Assessment of M2 macrophage markers may provide clinically relevant information to evaluate patient response to periodontal therapy and may be useful to target nonresponders with exaggerated immune responses. Aim Polarization of macrophages (Mφ) is a well‐controlled axis with considerable consequences in both the pro‐inflammatory and resolution phases of inflammation. We aimed to determine if periodontal therapy may instigate M1 to M2 Mφ polarization favoring resolution of inflammation within periodontal tissues. Methods Gingival biopsies were excised from subjects diagnosed with Stage III, Grade B periodontitis before and 4–6 weeks after nonsurgical periodontal therapy. Total RNA was isolated and pro‐ and anti‐inflammatory markers associated with Mφ polarization assessed by RT‐qPCR. Mice were subject to ligature‐induced periodontitis and gingival tissues collected after 8 days in‐situ or 10 days after ligature removal and M1 and M2 Mφ markers examined by RT‐qPCR and flow cytometry. Results In human samples, improvement in clinical parameters posttherapy correlates with reduced bacterial burden, downregulation in M1 (TNF‐α, STAT1, CXCL10, and miR‐155), and elevated levels of M2 (STAT6, TGM2, CCL22, and IL‐10) Mφ markers. In a murine model of resolution of LIP, we observed reduced levels of M1 Mφ markers cox2, iNOS2, F4/80+CD80+, and F4/80+CD86+ and elevated levels of M2‐like Mφ markers tgm2, arg1, F4/80+CD206+ and F4/80+CD163+ corroborated human findings. Conclusion Resolution of periodontal inflammation is associated with M1 to M2 Mφ polarization after nonsurgical periodontal therapy. Assessment of Mφ markers can provide relevant clinical information on the successful response of periodontal therapy and may be used to target nonresponders.
immunology
What problem does this paper attempt to address?